Syneron Medical Ltd. (ELOS), a worldwide leader in the medical aesthetic device business, strengthened its dedication to science and won the faith of aesthetic physicians, with the robust performance of its know how at the recently held 31st Annual Conference of the American Society of Laser Medicine and Surgery (“ASLMS”) in Grapevine, Texas.    

The company believes that its mixture of modern science, strong trust within the worldwide aesthetic community and favorable clinical results strengthens its position as an industry fore runner. It appreciates the opportunity that meetings like ASLMS provide to demonstrate its ability to create and commercialize scientific progress.

At the ASLMS meeting, Syneron and Candela, the company’s two brands, exhibited their latest innovative products, including the ePrime Energy-Based Dermal Remodeling System, which was prominent in an expert panel discussion attended by over 220 physicians.

These medical practitioners were excited to learn about this latest path-breaking aspect of facial enhancement. ePrime bypasses the epidermis and is the first less-invasive aesthetic device to accurately aim and deliver doses of radio frequency (“RF”) energy into the deep dermis to activate the growth of collagen and elastin for enhancement of skin tone.

Moreover, Syneron featured the elure Advanced Skin Lightening Technology, which is the only topical skin lightening item that enhances appearance by temporarily cutting down on the melanin pigment in the skin. Using a natural enzyme known as Melanozyme, the elure system leads to improvement in skin quality within only 30 days.

Syneron also showcased the GentleLASE Pro High Speed Hair Removal System, its cutting edge aesthetic laser. The futuristic GentleLASE Pro builds on the company’s existing well-regarded hair removal product line. Its performance has been enhanced to satisfy the needs of physicians by providing them quicker treatment times and other favorable attributes.

Syneron offers a comprehensive aesthetic product portfolio and a global distribution setup. Its knowledge allows medical practitioners provide sophisticated solutions for a wide range of aesthetic requirements such as wrinkle reduction, hair removal and body contouring. It competes with Cutera Inc. (CUTR) among others.


 
CUTERA INC (CUTR): Free Stock Analysis Report
 
SYNERON MED LTD (ELOS): Free Stock Analysis Report
 
Zacks Investment Research
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024 Haga Click aquí para más Gráficas Syneron Medical Ltd. - Ordinary Shares.
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024 Haga Click aquí para más Gráficas Syneron Medical Ltd. - Ordinary Shares.